CAMBREX CORPORATION (CBM) Tops Q3 EPS by 2c, Updates Guidance

CAMBREX CORPORATION (NYSE: CBM) reported Q3 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $81.1 million versus the consensus estimate of $94.25 million.

CAMBREX CORPORATION sees FY2014 EPS of $1.11-$1.19, versus prior guidance of $1.07-$1.15 and the consensus of $1.08.

For earnings history and earnings-related data on CAMBREX CORPORATION (CBM) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
• S&P 500 eyes record as retail slump, Iran risk set up pivotal week